TFO Wealth Partners’s Insmed INSM Stock Holding History

TFO Wealth Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14	Closed	-$295	–	1009
2023 Q3	$295	Buy	+14	New	+$320	﹤0.01%	663

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

TFO Wealth Partners's INSM Position: Q4 2023 in Review

TFO Wealth Partners sold out of Insmed (INSM) in Q4 2023, closing a stake of 14 shares — an estimated $295 sold.

TFO Wealth Partners first reported a position in INSM in Q3 2023 and held it in 1 quarter. The position peaked at $295 in Q3 2023. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

TFO Wealth Partners reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
TFO Wealth Partners sold 14 Insmed shares in Q4 2023, an estimated $295.
TFO Wealth Partners first reported a position in Insmed in Q3 2023 and held it in 1 quarter.
TFO Wealth Partners's Insmed position peaked at $295 in Q3 2023.
271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.